NYSE · SNN
Healthcare · Medical - Devices
$27.24
Up+$0.28 (+1.04%)
Updated Oct 10, 2026, 11:41 PM
SID Score
4.3/10
Composite research score
Smart Money
56/100
Neutral
Price performance · SNN
1M range · 0 trading sessions · Daily adjusted prices
SNN does not have enough price history for the selected period.
Data unavailable
Market data is busy. Please try again shortly.
The latest Smart Investors Daily articles mentioning SNN.
Company
Market Activity
Research & News
SNN research
Company profile and research snapshot.
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Jul 21, 2026 | Shore Capital | Buy | — |
| Jun 29, 2026 | RBC Capital Markets | Sector Perform | — |
| Jun 11, 2026 | Deutsche | Hold | — |
| Jun 10, 2026 | RBC Capital Markets | Sector Perform | — |
| May 21, 2026 | Jefferies | Buy | — |
No generated briefing is available yet.
Yahoo · Oct 1, 2026
Owens & Minor today named Carrie Childress executive vice president and chief marketing officer, effective immediately. In this newly created role, Childress becomes the first dedicated marketing executive in the company's more than 140-year history and will lead efforts to further strengthen the Owens & Minor brand and product portfolios.
Yahoo · Sep 23, 2026
The All-in-one system combines plates, cannulated screws and specialized instrumentation to streamline complex pelvic surgery Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces the launch of the EVOS PELVIC Plating System, the next evolution of the EVOS plating platform designed to address the unique challenges of pelvic and acetabular surgery. EVOS PELVIC System is built on the proven principles of the EVOS platform that has become a trusted choice for traum
Yahoo · Sep 23, 2026
The All-in-one system combines plates, cannulated screws and specialized instrumentation to streamline complex pelvic surgery Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces the launch of the EVOS PELVIC Plating System, the next evolution of the EVOS plating platform designed to address the unique challenges of pelvic and acetabular surgery. EVOS PELVIC System is built on the proven principles of the EVOS platform that has become a trusted choice for traum
Yahoo · Sep 22, 2026
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces it received 510(k) clearance from the U.S. Food and Drug Administration (FDA) and has completed the first surgical cases with LANDMARK Total Knee System, a next-generation knee replacement solution designed to replicate healthy knee anatomy and the knee’s natural motion and support a more personalized approach to total knee arthroplasty.As expectations for total knee arthroplasty continue to evolve, surgeons
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning SNN.
